US Patent Issued to Ose Immunotherapeutics, Etablissement Francais Du Sang, Assistance Publique-Hopitaux De Paris on March 25 for "Method effector cells using anti-CD127 antibodies for applications in cell therapy" (French Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,258,577, issued on March 25, was assigned to Ose Immunotherapeutics (Nantes, France), Etablissement Francais Du Sang (La Plaine St Denis, France) and Assistance Publique-Hopitaux De Paris (Paris).

"Method effector cells using anti-CD127 antibodies for applications in cell therapy" was invented by Bernard Vanhove (Reze, France), Nicolas Poirier (Treillieres, France), Sebastien Maury (Paris), Jose Cohen (Paris), Caroline Pilon (Saint Maurice, France) and Brigitte Birebent (Yebles, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to methods and preparations for sorting out T effector cells from human leukocytes using anti-CD127 ...